Fig. 3From: Melatonin improves non-alcoholic fatty liver disease via MAPK-JNK/P38 signaling in high-fat-diet-induced obese miceHistological analyses of liver steatosis. Representative images (400×) of H&E-stained (Upper) and Oil Red O-stained (Lower) liver sections from (a) HFD with melatonin, (b) HFD, (c) RD with melatonin, and (d) RDBack to article page